3,5,3′-triiodothyronine (T3) is a survival factor for pancreatic β-cells undergoing apoptosis

Journal of Cellular Physiology

Volumn 206, Issue 2, 2006, Pages 309-321

  Falzacappa, Cecilia Verga ^a,b   Panacchia, Laura ^a,b   Bucci, Barbara ^b   Stigliano, Antonio ^a,b   Cavallo, Maria Gisella ^c   Brunetti, Ercole ^b   Toscano, Vincenzo ^a   Misiti, Silvia ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; HYDROGEN PEROXIDE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL S NITROSOPENICILLAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; STREPTOZOCIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; THYROID HORMONE RELEASE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; HUMANS; INSULIN-SECRETING CELLS; RATS; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TRIIODOTHYRONINE;

EID: 30344440410     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20460     Document Type: Article

References (54)

1. Adcock R, Austin M, Duckworth WC, Solomon SS, Murrell LR. 1975. Human islets cell adenoma: Metabolic analysis of the patients and of tumor cells in monolayer. Diabetologia 11:527-535.
2. Bargsten G. 2004. Cytological and immunocytochemical characterization of the insulin secreting insulinoma cell line RINm5F. Arch Histol Cytol 67(1):79-94.
3. Baroni MG, Cavallo MG, Mark M, Monetini L, Stoherer B. 1999. Beta-cell gene expression and functional characterization of the human insulinoma cell line. CM J Endocrinol 161:59-68.
4. Barrera-Hernandez G, Soo Park K, Dace A, Zhan Q, Cheng SY. 1999. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity. Endocrinology 11(140):5267-5274.
5. Bonner-Weir S. 2000. Islet growth and development in the adult. J Mol Endocrinol 24:1-6.
6. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentiki M. 2001. Protein kinase C zeta activation mediates glucagon-like peptide-1 induced pancreatic beta-cell proliferation. Diabetes 50:2237-2243.
7. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110.
8. S6K cascade through PI3K in human fibroblasts. Mol Endo Jan 19(1):102-112.
9. Cavallo MG, Dotta F, Monetini L, Dionisi S, Previti M, Valente L, Toto A, Di Mario U, Pozzilli P. 1996. Beta-cell markers and autoantigen expression by a human insulinoma cell line: Similarities to native beta cells. J Endocrinol 150(1):113-120.
10. Cerasi E, Kaiser N, Leibowitz G. 2000. Type 2 diabetes and beta-cells apoptosis. Diabetes Metab 26(Suppl 3):13-16.
11. Chandra J, Zhivotovsky B, Zaitsev S. Juntti-Berggren L, Berggren PO, Orrenius S. 2001. Role of apoptosis in pancreatic β-cell death in diabetes. Diabetes 50(S1):S44-S47.
12. Chang I, Kim S, Kim JY, Cho N, Kim YH, Kim HS, Lee MK, Kim KW, Lee MS. 2003. Nuclear factor kappa B protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes 52(5):1169-1175.
13. Chang I, Cho N, Koh JY, Lee MS. 2003. Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes. Diabetologia 46:1220-1227.
14. Chen W, Salojin KV, Mi QS, Grattan M, Meagher TC, Zucker P, Delovitch TL. 2004. Insulin-like growth factor (IGF)-I-IGF-Binding Protein-3 complex: Therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 145(2):627-638.
15. Dickson LM, Rhodes CJ. 2004. Pancreatic β-cell growth and survival in the onset of type 2 diabetes: A role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287:E192-E198.
16. Francavilla A, Carr BI, Azzarone A, Polimeno L, Wang Z, Van Diehl DH, Subbotin V, Prelich JG, Starzl TE. 1994. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 20:1237-1241.
17. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. 2003. PI3-K/Akt and apoptosis: Size matters. Oncogene 22:8983-8998.
18. Giannoukakis N, Mi Z, Rudert WA, Gambotto A, Trucco M, Robbins P. 2000. Prevention of beta-cells dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther 7:2015-2022.
19. Giannoukakis N, Pietropaolo M, Trucco M. 2002. Therapeutic strategies for type 1 and type 2 diabetes mellitus. Diabetes Nutr Metab 15(3):173-203.
20. Gunther L, Berbera PO, Haga M, Brouard S, Smith RN, Scares MP, Bach FH, Tobiasch E. 2002. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51(4):994-999.
21. Hui H, Nourparvar A, Zhao X, Perfetti R. 2003. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase a- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrionology 144(4):1444-1455.
22. Hui H, Dotta F, Di Mario U, Perfetti R. 2004. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol 200:177-200.
23. Ikeuchi T, Shimoke K, Kubo T, Yamada M, Hatanaka H. 1998. Apoptosis-inducing and-preventing signal transduction pathways in cultured cerebellar granule neurons. Hum Cell 11:125-140.
24. Jill DJ, Strutt B, Arany E, Zaina S, Coukell S, Graham CF. 2000. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets. Endocrinology 141:1151-1157.
25. King KL, Cidlowski JA. 1998. Cell cycle regulation and apoptosis. Annu Rev Physiol 60:601-617.
26. Koibuchi N, Chin W. 2000. Aberrant postnatal cerebellar development in transgenic mouse expressing a dominant negative thyroid hormone receptor. Proc Annu Meet Endocr Soc 81d Toronto Canada, 374 p.
27. Ledda-Columbano GM, Ferra A, Loi R, Shinozuka H, Columbano A. 2000. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinoma. Cancer Res 60:603-609.
28. Lee JT, Lebenthal E, Lee PC. 1990. Thyroidal regulation of rat pancreatic nuclear triiodothyronine receptor during postnatal development. Endocrinology 126(1):209-215.
29. Lingor MK, Dickinson LM, Wrede CE, Briaud I, McCuaig JF, Myers MG, Jr., Rhodes CJ. 2003. Decreasing IRS-2 expression in pancreatic β-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression. Mol Cell Endocrinol 209:17-31.
30. Mandrup-Poulsen T. 2001. Beta-cell apoptosis: Stimuli and signaling. Diabetes 50(S1):S58-S63.
31. Mathis D, Vence L, Benoist C. 2001. β-cell death during progression to diabetes. Nature 414:792-798.
32. Mauricio D, Mandrup-Poulsen T. 1998. Apoptosis and the patogenesis of IDDM: A question of life and death. Diabetes 47:1537-1543.
33. Morgan DO. 1997. Cyclin-dependent kinases: Engines, clocks and microprocessors. Annu Rev Cell Dev Biol 13:261-291.
34. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K. 2002. Thyroid hormone action is disrupted by Bisphenol A as an antagonist. J Clin Endocrinol & Metab 87(11):5185-5190.
35. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C. 2001. Regulation of beta-cell mass by hormones and growth factors. Diabetes 50(Suppl 1):S25-S29.
36. Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E, Mori M. 2001. Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. PNAS 98(19):10845-10850.
37. Perfetti R, Zhou J, Doyle ME, Egan JM. 2000. GLP-1 induces cell proliferation, PDX-1 expression and increases endocrine cell mass in pancreas of old, glucose intolerant rats. Endocrinology 141:4600-4605.
38. Pibiri M, Ledda-Columbano GM, Cossu C, Simula G, Menegazzi M, Shinozuka H, Columbano A. 2001. Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J 15:1006-1013.
39. Poitout V, Olson LK, Robertson RP. 1996. Insulin-secreting cell lines: Classification, characteristics and potential applications. Diabetes Metab 22(1):7-14.
40. Rasilainen S, Nieminem JM, Levonen AL, Otonkoski T, Lapatto R. 2002. Dose-dependent cysteine-mediated protection of insulin-producing cells from damage by hydrogen peroxide. Biochem Pharmacol 63(7):1297-1304.
41. Ribeiro RC, Apriletti JW, Wagner RL, West BL, Feng W, Huber R, Kushner PJ, Nilsson S, Scanlan T, Fletterick RJ, Schaufele F, Baxter JD. 1998. Mechanisms of thyroid hormone action: Insights from X-ray cristallographic and functional studies. Rec Prog Horm Res 53:351-394.
42. Shahrara S, Drvota V, Sylven C. 1999. Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues. Biol Pharma Bul 22(10):1027-1033.
43. Shi YB, Su Y, Ii Q, Damjanovski S. 1998. Autoregulation of thyroid hormone receptor genes during metamorphosis: Roles in apoptosis and cell proliferation. Int J Dev Biol 42:107-116.
44. Sjoholm A. 1995. Regulation of insulinoma cell proliferation and insulin accumulation by peptides and second messengers. Ups J Med Sci 100(3):201-216.
45. Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permute MA. 2002. Glucose promotes pancreatic islet β-cell survival through a PI 3-kinase/Akt signalling pathway. Am J Physiol Endocrin Metabol 283:E748-E793.
46. Thomas D, Yang H, Boffa DJ, Ding R, Sharma VK, Lagman M, Li B, Hering B, Mohanakumar T, Lakey J, Kapur S, Hancock WW, Suthanthiran M. 2002. Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation 74:1489-1496.
47. Trentin AG, Alvarez-Silva M, Moura Neto V. 2001. Thyroid hormone induces cerebellar astrocytes and C6 glioma cells to secrete mitogenic growth factors. Am J Physiol Endocrinol Metab 281:E1088-E1094.
48. Tuttle RL, Gill NS, Pugh W, Lee JP, Kpeberlein B, Furrth EE, Polonsky NS, Naji A, Birnbaum MJ. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt/PKB alpha. Nat Med 7:1133-1137.
49. Vermeulen K, Berneman ZN, Van Bockstaele DR. 2003. Cell cycle and apoptosis. Cell Prolif 36:165-175.
50. Webster CR, Anwer MS. 1998. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 27:324-1331.
51. Wrede CE, Dickson LM, Lingohr MK, Briaud I, McCuaig JF, Rhodes CJ. 2002. Protein kinase B/Akt prevents fatty acid induced apoptosis in pancreatic β cells (INS-1). J Biol Chem 277:49676-49684.
52. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
53. Zhang J, Lazar MA. 2000. The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466.
54. Zinke A, Schmoll D, Zachmann M, Schmoll J, Junker H, Grempler R, Kirsch G, Walther R. 2003. Expression of thyroid hormone receptor isoform alpha 1 in pancreatic islets. Exp Clin Endocrinol Diabetes 111(4):198-202.